Dietary Astragalus polysaccharides support maternal humoral immunity and mammary alveolar development with associated metabolic and transcriptional responses in sows
Received: Aug 25, 2026; Revised: Sep 18, 2026; Accepted: Nov 18, 2026
Published Online: Nov 18, 2026
Abstract
The periparturient period is associated with metabolic and immunological challenges in sows that may influence lactational performance and piglet growth. Astragalus polysaccharides (APS) are botanical bioactive ingredients with immunomodulatory and metabolic regulatory properties, but their effects on maternal physiological adaptation and mammary responses remain incompletely understood. This study evaluated dietary APS supplementation in 24 multiparous sows receiving either a basal diet or 400 mg/kg APS from 20 days before farrowing until weaning. APS supplementation increased sow feed intake (p = 0.0461) and tended to increase estimated milk yield (p = 0.0808) and piglet average daily gain (p = 0.0864). Mammary alveolar area was greater (p < 0.0001), while serum IgG, IgM, and IL-10 concentrations were higher after BH correction (adjusted p < 0.05); circulating pro-inflammatory cytokines showed no significant between-group differences. Exploratory serum metabolomics suggested increases in 2,5-diaminopentanoic acid, 5-aminovaleric acid, creatinine, and phosphatidylethanolamine species, together with decreases in chenodeoxycholic acid glycine conjugate and hypotaurine. Exploratory mammary transcriptomic analysis highlighted immune-related KEGG pathways, particularly IL-17, TNF, and NF-κB signaling, together with representative genes involved in cytokine and chemokine signaling, epithelial adaptation, and tissue regulation. Pooled exploratory metabolomic-transcriptomic analysis further identified distinct association patterns. Amino acid-related metabolites were mainly associated with immune and chemokine genes, bile acid-related metabolites with immune and xenobiotic-response genes, and phosphatidylethanolamine species with genes involved in mammary cellular activity. Collectively, APS supplementation was associated with enhanced maternal humoral immune status and mammary alveolar development, accompanied by serum metabolic and mammary transcriptional responses that may contribute to maternal physiological adaptation during lactation.